APCI drugs

An on-line chromatography/atmospheric pressure chemical ionization tandem mass spectrometry (LC-APCI/MS/MS) methods was developed for rapid screen of pharmacokinetics of different drugs, including 5 (98RCM1216). The electron impact mass spectrum of 5 and ethyl 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7Ff-pyrido[l,2,3- fe]-l,4-benzoxazine-6-carboxylate was reported (97MI28). Electron impact/Fourier transform... 

Applications APCI-MS is often more widely applicable than ESI-MS to the analysis of classes of compounds with a low molecular weight, such as basic drugs and their metabolites, antibiotics, steroids, oestrogens, benzodiazepines, pesticides, surfactants, and most other organic compounds amenable to El. LC-APCI-MS has been used to analyse PET extracts obtained by a disso-lution/precipitation procedure [147]. Other applications of hyphenated APCI mass spectrometric techniques are described elsewhere LC-APCI-MS (Section 7.33.2) and packed column SFC-APCI-MS (Section 73.2.2) for polar nonvolatile organics. 

Ion mobility spectrometry (IMS) [3,12] is the most widely used instrument for drug detection. The sample is heated to vaporize the analyte, which is then ionized by atmospheric (ambient) pressure chemical ionization (APCI) [3]. The resulting gas-phase ions travel through a drift tube and are separated by their distinct velocities (mobilities) in a weak electrostatic field. IMS instruments use ambient air or nitrogen as the carrier gas, making it particularly adaptable to field applications. 

Column size is another important consideration. For equipment designed for most routine laboratory HPLC situations the relative sensitivity of APTelectrospray instruments is better at low flow rates (0.2-0.8 mL/min) whereas the relative sensitivity of APCI instruments is enhanced at high flow rates (0.5-2 mL/min). As a result, small columns are appropriate for API-electrospray/MS and, if only one or two compounds of interest are found in a particular sample, high-resolution separations are not necessary. For APTelectrospray analysis of complex samples, 150 mm x 4.1 mml.D., 3 pm columns (flow 0.5-1.0 mL/min) are usually sufficient. For drug quantification involving analysis of single or low numbers of compounds, small columns such as 30 mm x 2.1 mm I.D., 3.5 pm columns (flow rate 0.2-0.4 mL/min) provide sufficient separation and a saving in both column cost and solvent utilization. The reduced injection volume required for the small columns often results in better resolution and increased sensitivity. 

LC/MS is the ultimate analytical technique, which combines the versatility of HPLC with the identification power of MS. The weak link in LC/MS has always been the interface which connects the liquid stream at atmospheric pressure to the high vacuum present inside the mass spectrometer. The development of several atmospheric pressure interfaces, electrospray and atmospheric pressure chemical ionization (APCI), has contributed to the tremendous success and popularity of LC/MS and LC/MS/MS in bioresearch, drug discovery, combinatorial analysis and pharmacokinetic assays. This topic is covered in more depth in a later chapter. 

Dams et al. [18] developed a validated quantitative LC-APCI-MS-MS method for simultaneous determination of multiple illicit drugs and their metabolites in oral fluid. This substrate is being increasingly popular for forensic applications as it provides information on recent use, similarly to blood plasma/serum, although it can be obtained with a simple, noninvasive, collection. Sample pretreatment, though limited to protein precipitation with acetonitrile, was sufficient to avoid matrix effect (see Figure 20.2). 

At present, the most powerful and promising interfaces for drug residue analysis are die particle-beam (PB) interface that provides online EI mass spectra, the thermospray (TSP) interface diat works well with substances of medium polarity, and more recently the atmospheric pressure ionization (API) interfaces that have opened up important application areas of LC to LC-MS for ionizable compounds. Among die API interfaces, ESP and ISP appear to be the most versatile since diey are suitable for substances ranging from polar to ionic and from low to high molecular mass. ISP, in particular, is compatible with the flow rates used with conventional LC columns (70). In addition, both ESP and ISP appear to be valuable in terms of analyte detectability. These interfaces can further be supplemented by preanalyzer collision-induced dissociation (CID) or tandem MS as realized with the use of triple quadrupole systems. Complementary to ESP and ISP interfaces with respect to the analyte polarity is APCI with a heated nebulizer interface. This is a powerful interface for both structural confirmation and quantitative analysis. 

Unlike with GC-MS, quality criteria for identification of drug residues by LC-MS have not been yet defined within the European Union, but this is currently under review. Criteria for GC-MS stipulate the measurement of preferably at least four diagnostic ions. However, this is not always possible with LC-MS because most compounds will only produce an M ion in positive mode or a M ion in negative mode, with little fragmentation when using thermospray (TSP), electrospray (ESP), or atmospheric pressure chemical ionization (APCI). Even where the ions and ratios are in agreement, there will be still possibility of misidentification. For this reason, mass spectra data are often interpreted with additional supporting data such as the LC retention times, as, for example, in the LC-MS analysis of sulfadimethoxine and sulfadoxine that present identical mass spectra (24). 

Over the past two decades, QMF-based quantification assays have become the technique of choice for quantification of drug candidates and their metabolites. Combining a mass spectrometer with LC provides an additional degree of selectivity and makes the combined technique the method of choice for quantitative bioanalysis of drugs and metabolites. Among the mass spectrometer types, QMF are ideal for coupling with LC and atmospheric pressure ionization sources (ESI, APCI, APPI, DART, DESI, etc.) because QMFs have the lowest voltage requirements and vacuum requirements. 

Yu, K., Di, L., Kems, E. H., Li, S. Q., Alden, P., and Plumb, R. S. (2007). Ultra-performance liquid chromatography/tandem mass spectrometric quantification of structurally diverse drug mixtures using an ESI-APCI multimode ionization source. Rapid Commun. Mass Spectrom. 21 893-902. 

To demonstrate that the proposed methods are suitable for structural elucidation of isomeric metabolites and derivatives in biological matrices, human plasma was spiked with the mixture of DL, 6-OH-DL, 3-OH-DL, /V-OH-DL, and 1-pyridine-/V-oxide-DL. The resulting sample was extracted and analyzed by LC-MS and LC-MS/MS in ESI and APCI modes as described above. HDX was successfully performed online when the extract was injected directly onto the HPLC column without drying and reconstituting the sample in a deuterated solvent. In general, there were no differences between the results obtained for the spiked plasma extract and for the mixture of the standard compounds, which indicates that the LC-MS methods with HDX described here are applicable for the analysis drug-derived material in plasma or other biological matrices. 

The use of SRM methods for quantitative bioanalysis represents increased dimensions of mass spectrometry analysis. SRM methods that use APCI-LC/MS/MS for the quantitative analysis of an antipsychotic agent, clozapine, in human plasma were described by Dear and co-workers (Dear et al., 1998). Preclinical development studies of clozapine in rats and dogs used HPLC with fluorescence detection (FLD). With this method, a better limit of quantitation (LOQ) of 1 ng/mL was obtained. As the compound moved into the clinical stages of development, a more sensitive method of analysis was required to obtain rapid metabolic information in support of drug safety evaluation studies. A standard LC/MS/MS method is used for the quantitative analysis of clozapine (I) and four metabolites (II-V) in human plasma (Figure 6.34). 

Kollroser M, Schober C (2002) Simultaneous determination of seven tricyclic antidepressant drugs in human plasma by direct-injection HPLC-APCI-MS-MS with an ion trap detector. Ther Drug Monit 24 537-544... 

Klys M, Rojek S, Kulikowska J, Bozek E, Scislowski M (2007) Usefulness of multi-parameter opiates-amphetamines-cocainics analysis in hair of drug users for the evaluation of an abuse profile by means of LC-APCI-MS-MS. J Chromatogr B Analyt Technol Biomed Life Sci 854(1—2) 299—307. doi S 1570-0232(07)00337-6 [pii] 10.1016/j.jchromb.2007.04.040... 

In drug analysis, LC-MS usually means reversed phase liquid chromatography coupled to mass spectrometry. Although normal phase LC can be used as well (especially in combination with atmospheric pressure chemical ionization - APCI), predominantly reversed phase LC is used in drug research and drug analysis due to the typical physical and chemical properties of the analytes (e.g. polarity, size). 

Compared with APCI, APPI is more sensitive to the experimental conditions. Properties of solvents, additives, dopants or buffer components can strongly influence the selectivity or sensitivity of the detection of analytes. Nevertheless, this technique allows the ionization of compounds not detectable in APCI or ESI, mainly non-polar compounds. For these last compounds, APPI is a valuable alternative. Thus, APPI is a complementary technique to APCI and ESI. However, for a given substance it remains difficult to predict which ionization source (APPI, APCI or ESI) will give the best results. Only preliminary tests will allow the choice of the best ionization source. APPI appears to be efficient for some compound classes such as flavonoids, steroids, drugs and their metabolites, pesticides, polyaromatic hydrocarbons, etc. [85],... 

Pseudomolecular Ions. In contrast to the traditional MS, the highest mass peaks in ESI/APCI spectra are not always the molecular ion of interest. Instead, pseudomolecular ions, or noncovalent complex ions, are commonly observed. The pseudomolecular ions are generally formed by the analyte-adduct interaction in the solution system that is preserved as a result of the soft ionization of the ESI/APCI process. These ions are also formed by analyte-adduct gas-phase collisions in the spray chamber [49]. The exact mechanisms of how the analyte adducts are formed in ESI/APCI still remain unresolved at this point. More often than not, the adduct ion formation is a major cause for the low detection limit for ESEAPCI MS. However, these associative processes have also created interest in the study of drug-protein/ drug-oligonucleotide gas-phase complexes that benefit from the ability of ESI/APCI MS analysis. 

---